Tests of hypotheses associated with the functional linear model are investigated under smoothness assumptions. The tests considered are those which use a quadratic-form test statistic calculated on a high-dimensional discrete model that is obtained by Fourier transformation.
At the same time, the functional parameter β(t) in (1) is to be assumed "smooth," which, from an intuitive standpoint, means that each β j is a conglomeration of mainly large-scale, sweeping shapes. Thus a key issue in testing is how to exploit this smoothness assumption, so as not to waste statistical power attempting to distinguish "rough" aspects of the model (i.e., the small-scale wiggly shapes). This is especially important in high-dimensions, where the vastness of the parameter space requires a careful management of power. Observing that typical constructions of the discrete model (2) assign smaller indices to the components that capture smoother model attributes, such considerations lead our attention to test statistics that place primary emphasis on these lower-indexed components. Specifically, the central concern of this article is the performance of test statistics having a quadratic form,
where each 0 < w n,j ≤ 1, and typically w n,j → 0 as j → ∞ to achieve the desired emphasis on the lower indices.
This approach shall be referred to as "tapering," and the main objective of this article is to deduce sensible configurations of the tapering mechanism. The investigation will evaluate tests based on (4) under the performance criteria of "rates of testing" theory, whose details are laid out in Section 2. The results establish general performance bounds and identify settings that yield optimal performance within this class of tests. In addition, a detailed and broad framework for characterizing the performance of individual tests is developed, and demonstrated on several examples. The bounds and characterizations readily translate to recommendations on the use of tapering mechanisms in FDA practice, and it is expected the theoretical toolbox developed here would provide quick evaluation of many tests borrowed from other contexts for use in FDA.
Why study tests based on quadratic forms?
A well-known alternative to tapering is "truncating," which places emphasis on low-indexed components by modifying an unweighted quadratic form, Q n = n pn j=1 Y n,j 2 , to a lowerdimensional analogue, N n,kn = n k n j=1 Y n,j 2 , wherek n is a "working dimension" specified through a data-driven diagnostic. This form of statistic is known as "Neyman's truncation," for which Raynor and Best (1989) provide a good general discussion. An empirical investigation of this approach is described in Spitzner (2006) , which verifies the intended emphasis on low indices. There is extensive discussion on choosingk n by such diagnostics as AIC and BIC, and their generalizations, as discussed in Eubank and Hart (1992) , Eubank and LaRiccia (1992) , Inglot and Ledwina (1996) , Eubank (2000) , Aerts, Claeskens, and Hart (2000) , and Claeskens and Hjort (2004) , among others. Another approach is to selectk n as the k = 1, . . . p n that maximizes the diagnostic AN n,k = (N n,k − k)/ √ k. The associated test based on N n,kn is then the "adaptive Neyman test," which was introduced in Fan (1996) , and has been developed in Fan and Lin (1998) , Fan and Huang (2001) , and Fan, Zhang, and Zhang (2001) . In particular, Fan and Lin (1998) develop both the adaptive Neyman test and other approaches based on "thresholding" (some of whose details are given in Section 1.3) for use in FDA.
Existing theory suggests that, from a strict performance viewpoint, comparisons between tapering and truncation may very well lead one to prefer truncation, or even thresholding. For instance, within rates-of-testing theory Fan, Zhang, and Zhang (2001) establish that the adaptive Neyman test can achieve the asymptotic "adaptive" optimality criterion of Spokoiny (1996) .
Moreover, Spokoiny (1996) describes an adaptively optimal test based on "hard" thresholding.
On the other hand, the results here (in Theorem 3, below) establish that tests based on quadratic forms are sub-optimal with respect to this criterion, deeming them less favorable than tests using truncation or thresholding. Such sub-optimality does not shut the door on quadratic forms, however, for there remain good reasons to use them in FDA, and to study their performance.
The first is that tests based on quadratic forms arise through a formal Bayesian construction, thereby justifying their use as a means of conforming to a rigorous test-construction principle.
To see this, suppose the model (2) is such that Y j |θ j ∼ N (θ j , I/n), and a prior structure is specified by placing a prior mass on H 0 and taking each θ j |H 1 ∼ N (0, v j I/n), independently across j. The posterior null probability P [H 0 |Y j ; j = 1, . . . , p n ] is then a monotone function of the quadratic form (4) with w n,j = {1 − 1/(1 + v j )}. A fully-Bayesian inference framework based on this calculation is developed in Spitzner (2008) , which makes use of the results deduced here and discusses applications. For present purposes, just the fact of having a Bayesian testconstruction provides the requisite motivation.
There is emerging literature suggesting a Bayesian flavor for some existing optimal tests as well, however not in the rigorous sense by which tests based on quadratic forms may be constructed. For instance, Abramovich et al. (2007) show that hard-thresholding operations can arise from estimation-type Bayesian constructions, thus admitting a formulation of Spokoiny's optimal test as the the norm of a hard-thresholding Bayesian estimator. Yet, test statistics constructed this way do not through a monotone transformation become P [H 0 |Y j ; j = 1, . . . , p n ], and so do not quite provide what is needed for the testing problem. This is not to say that optimality is impossible using formal Bayesian constructions, only that neither truncation nor thresholding readily conform to Bayesian test-construction, leaving the tapering approach as a desirable way to proceed.
Other reasons to use quadratic forms are pragmatic. It is occasionally the case in consulting or interdisciplinary situations that the "low maintenance" of a procedure is as important as its good performance, in order to assure correct implementation when the statistician is no longer closely involved in a project. For instance, a common, novice mistake one would want to avoid is the inadvertent treatment of the truncation statistic N n,kn through its conditional distribution givenk n . If there is concern over the possibility that it or similar mistakes will be made, a quadratic form would be attractive since it explicitly uses of all of the data, and gives no suggestion to condition on any particular dimension. Furthermore, quadratic forms are low maintenance in that their distributions may be handled through well-known analytical approximations (see, e.g., Mathai and Provost, 1992, sec. 4.6) , whereas those of statistics involving truncation or thresholding usually require simulation. Given modern computing power, this may be a trivial limitation in straightforward testing applications, but the availability of approximations can be a great help when bundling high-dimensional tests into more complicated statistical procedures, where the setting of parameters by simulation can be a heavy burden. For instance, Spitzner and Marshall (2008) make use of quadratic forms, and their approximate distributions, to develop a procedure for high-dimensional sequential monitoring of nonparametric surfaces.
Finally, the tapering approach is important because quadratic forms are used widely in statistics, and arise frequently in the development of new high-dimensional methodologies.
For instance, Fan, Zhang, and Zhang (2001) derive a quadratic form (4) with w n,j → 0 as j → ∞ as the test statistic of the maximum likelihood ratio test under model (2) subject to geometric constraints that model smoothness. (Details of their test statistic and the constraints are described in Section 1.3.) In an FDA application, Spitzner and Woodall (2003) customize a high-dimensional test to emphasizes the variability represented by an extraneous data set of "template" functions. Using an adaptation of discriminant analysis, the resulting test statistic is a quadratic form (4) with the weights w n,j defined as the eigenvalues of a matrix describing the modes of variability that discriminate the templates. In goodness-offit testing, Eubank and LaRiccia (1992) study the classical Cramér-von Mises statistic via the
2 ), and also test statistics of the
2 ), where w n,j = (1 + j 2 ξ n ) −2 and ξ n is a "bandwidth"
parameter. All of these statistics are either intended or are reasonable candidates for use in
FDA.
The present problem may be cast in part as a constrained optimization problem in rates of testing theory, whose constraint is defined by its focus on tests based on quadratic forms. The observations above motivate our study of this problem for the purpose of providing practical recommendations for situations where formal construction or methodological familiarity is an important concern. It is moreover interesting theoretically to make precise the shortfall from unconstrained optimality that is inherent in the tapering approach. Furthermore, as FDA develops, and as test procedures continue to be borrowed from other contexts, it is expected that many procedures yet to be proposed will, through suitable manipulation, be understood as tapering mechanisms. To understand and improve upon their performance, it will be a great convenience to have available the tools developed here.
An asymptotic framework for functional data analysis
The rates-of-testing criteria, upon which the present evaluation is built, are cast within an asymptotic setup such that p n → ∞ as n → ∞, while the magnitude of error in (2) shrinks at the rate n −1/2 . This framework is often applied to evaluate procedures that are intended for use in FDA, but a peculiarity is that the formulation of FDA models does not explicitly require a connection between p n and n. An understanding of how these asymptotics are nevertheless relevant in FDA, and the special issues that arise in that context, can be gleaned from the translation from the functional model (1) to the discrete model (2), which is now described.
It is supposed the translation from (1) to (2) arises through a Fourier decomposition of the functional linear model (1) in the following way. The functional measurements are assumed to have been taken along a dense, finite grid that is common to all Y i (t): the points of the grid are t k = k/p for k = 1, . . . , p and some fixed, large p (which may not be p n ). The data associated with the curve
(In more general situations the the grid may change from curve to curve, but to avoid additional complication it will be assumed a good approximation to the present setup is available, e.g., by interpolating measurements onto a fixed grid.) Set ψ j (t) = p −1/2 cos(2πjt) for j even and ψ j (t) = p −1/2 sin(2πjt) for j odd, j = 0, 1, . . . , p. Now translate the continuous model (1) to discrete vectors
An often-appropriate assumption has each ǫ i a stationary process given by
is, across integer k, a mean-zero independent and identically distributed sequence with finite fourth moment, and ∞ j=−∞ |γ j ||j| 1/2 < ∞. When this assumption is valid, Theorem 10.3.2 of Brockwell and Davis (1991) implies that pCov(Y * 2
is uniformly bounded across j = k and p. Thus, Fourier decomposition provides a means to decorrelate the functional linear model, while the statistics (5) capture its core structure. Let us assume this error structure and proceed as follows.
A linear transformation tailors the statistics (5) to the functional linear hypothesis. Set
and define the Y n,j in (2) according to
where
. The remaining objects defining (2) are
The astute reader will notice that p n is never connected to n, but is instead constrained only by the resolution of the grid t 1 , . . . , t p , which to avoid numerical error requires p n ≤ p. It is possible that p n would be influenced by other modeling assumptions as well. For instance, in Spitzner, Marron, and Essick (2003) , the authors make a subjective decision to ignore the largest j in response to observed defects in the ability of (ψ j ) to decorrelate the model. At any rate, the translation of (1) to (2) provides justification for taking p n → ∞ by illustrating how it forms an appropriate abstract conceptualization for repeated measurement of functional data: p n → ∞ represents a situation where the grid t 1 , . . . , t p is to become increasingly dense, and in the limit capture of all available information about the sampled curves. In this way, the asymptotic setup reflects the global perspective of the functional linear hypothesis, its concern with L T β(t) = 0 across all t. Nevertheless, a hallmark of the FDA context is that, because p n is not explicitly connected to n, it is difficult to pinpoint the rate at which p n → ∞, even hypothetically. To reflect this, an important concern of this article is the sensitivity of test performance on the rate of p n → ∞. This is an undeveloped aspect of the existing rates-of-testing theory, and a novel aspect of the present study.
Geometry and performance
To be specific, the smoothness assumption on β(t) is made precise, for present purposes, through restriction of the mean vectors of the discrete model (2) to the geometry
where M > 0 and s > 1/2 are fixed constants, and θ j 2 = ν k=1 θ 2 jk . The notations = 4s + 1 > 3 shall also be used. The bound on the norm in (6) models smoothness by restricting expression of the higher-indexed θ j , with larger s making the restriction stronger. Moreover, Parseval's identity implies that θ ∈ B s,M is equivalent to the assumption that each β j is an element of a Sobolev ball {β : Adams and Fournier, 2003.) This provides motivation for the precise form of (6) and a relevant connection to the underlying functional representation.
The basic components of rates-of-testing theory are laid out Ingster (1993) , Spokoiny (1996) , Lepski and Spokoiny (1999) , Horowitz and Spokoiny (2001) , and Gayraud and Pouet (2005) , among others. Most relevant to present purposes are Ingster (1993) and Spokoiny (1996) , whose respective "minimax" and "adaptive-minimax" rates establish optimal performance bounds.
What distinguishes these bounds is the manner in which s in (6) is regarded: the nonadaptive context treats just one value of s, while the adaptive context requires good-performance across a range of s.
Deferring the description of these bounds to Section 2, a summary of relevant, available results is as follows. Ingster (1993) demonstrates that the unweighted quadratic form n pn j=1 Y n,j 2 achieves a minimax rate provided p n ≍ n 2/s . Fan, Zhang, and Zhang (2001) deduce the same property of the infinite quadratic form Q ∞ n = n ∞ j=1 w n,j Y n,j 2 , with weights w n,j = {1 − j 4s ξ 2 n /(1 + j 2s ξ n ) 2 } and ξ n = n −4s/s . In that same paper, the adaptive Neyman test with p n = n is shown to achieve Spokoiny's adaptive-minimax rate of testing for every s > 1/2. Fan (1996) , in which the adaptive Neyman test initially appears, also discusses "hard-" and "soft-" thresholding test statistics of the form Spokoiny (1996) takes an interesting approach in evaluating similar hard-thresholding tests. Controlling ξ H,n and p n as functions of s, first deduced are test statistics HT n = HT n (s) that achieve
Ingster's nonadaptive-minimax rate. The maximum of standardized versions of the HT n (s) over s * < s < s * is then shown to provide a test statistic that achieves an adaptive-minimax rate across s * < s < s * . From these properties it is seen that thresholding offers a third highperformance option for high-dimensional testing, besides tapering and truncation, but from examination of the form of HT n the intuition by which it embodies an emphasis on low-indexed, smooth components is not obvious.
Organization
Section 2 lays out the technical framework of rates-of-testing theory and states the paper's main results. The results of Section 2 are quite technical, thus Section 3 provides interpretation.
That section also discusses examples and implications, and makes recommendations for FDA practice. Concluding discussion appears in Section 4. All proofs are removed to Section 5.
Rates of testing for the tapering mechanism
In this section, rates-of-testing criteria are defined in detail, after which Theorem 1 translates them to criteria that are specific to tapering approach. Section 2.1 refines this translation by introducing terminology and basic results that detail roles of the weights w n,j and dimensionality parameter p n of the quadratic form (4) in determining performance. Section 2.2 characterizes the performance of a large class of tests based on quadratic forms, and establishes performance bounds for the tapering approach in general.
To describe the rates-of-testing framework, recall the geometry (6), fix s > 1/2, M > 0, and for each n let φ n = φ n (Y n,1 , . . . , Y n,pn ) be a test of (3) for which lim n P 0 [φ n = 1] ≤ α, where α ∈ (0, 1) is fixed. Here we use the notation P θ to denote probabilities under the model (2) for a specific θ = (θ 1 , θ 2 , . . .) and fixed n. Rates-of-testing criteria are formulated from sequences
Ingster (1993) establishes that for no test does any δ n = o(n −2s/s ) satisfy (7), but there is a test, described in Section 1.3, for which δ n = n −2s/s satisfies (7). This identifies the rate n −2s/s as minimax for the geometry B s,M at a specific s. Suppose now that for each s ∈ (s * , s * ) one is to consider a separate sequence (δ n (s)), and setδ n (s) = {n Spokoiny (1996) establishes that for no test is (7) satisfied uniformly across s * < s < s
each such s. It is also shown there is a test, also indicated in Section 1.3, for which δ n k (s) =δ n (s) does satisfy (7) uniformly across s * < s < s * . This identifies the ratesδ n (s) as adaptive-minimax
This paper's first main result, on which all subsequent results are based, rewrites the criterion (7) in terms of the parameters of a quadratic form.
Theorem 1. Assume the model (2) and suppose (Q n ) is a sequence of test statistics with each
Q n as in (4) for associated sequences (w n,j ) and (p n ) such that each 0 < w n,j ≤ 1 and p n → ∞
and U n (p) = U n (p, p). Suppose at each n the e n,jk are independent across k, and
Suppose further that each e n,jk is such that E[e n,jk ] = 0, V [e n,jk ] = 1, E[e 
where q n = {δ n /M } −1/s . The same conclusion holds if the Y n,jk in Q n are replaced with
k, and l.
Observe the conclusion of Theorem 1 does not depend on a specific value of α. However, the value of M does matter in cases where
complicates the conventional notion that the "rate" of δ n is invariant to leading constants.
Nevertheless, Corollary 1.1.iii,iv, below, describe how the δ n satisfying (10) 
and so the criterion (9) is satisfied.
In the typical case where the σ 2 j (of Section 1.2) are unknown, the test statistic Q n in (4) would be replaced byQ n = n 
( Fan and Lin, 1998, sec. 3.4 , discuss other estimates of σ 2 j based on smoothing across j.) It is readily verified using the delta rule that
The conclusions of Theorem 1, therefore remain valid withQ n replacing Q n .
Tapering schemes and refinement schemes
Building on the criteria of Theorem 1, the next step of the investigation is to describe the individual roles of weight sequence and dimensionality parameter in determining performance.
For this purpose a precise terminology related to these parameters now is laid down, and basic results are derived.
To start, let us work with the dimensionality parameter p n and the parameter δ n .
Definition 1.
A refinement scheme is a positive, integer sequence (p n ) for which p n → ∞. A separating sequence is a positive sequence (δ n ) for which δ n → 0. Now fix constants s > 1/2 and M > 0 and a weight sequence (w n,j ) for which each 0 < w n,j ≤ 1:
(i) Fix a refinement scheme (p n ). If (δ n ) is a separating sequence for which (10) holds,
In that case, the rate at which δ n → 0 defines a conditional rate of testing for (w n,j ) at (s, M ) given (p n ).
(ii) Leaving the refinement scheme ambiguous, a separating sequence (δ n ) is said to be allowed
and, in addition, each separating sequence (δ * n ) that is allowed by (w n,j ) at (s, M ) has δ n = O(δ * n ), then (δ n ) is said to be minimally allowed by (w n,j ) at (s, M ). In that case, the rate at which δ n → 0 defines an (unconditional) rate of testing for (w n,j ) at (s, M ).
Reference to specific (w n,j ), s, or M may be omitted when obvious in context.
The term "refinement scheme" in Definition 1 is intended to reflect a densely-measured functional model that has been translated to (2), in the manner described in Section 1.2. It associates the higher-indexed dimensions of the discrete model (2) with more "refined" measurement of a curve sample. Theorem 2, below, verifies the existence of minimally allowed separating sequences.
Continuing on with our description, it will be convenient to have weight sequences classified into categories as follows.
Definition 2. A sequence (w n,j ) such that 0 < w n,j ≤ 1, as in (4), is said to be a weighting scheme. It is called fixed if (w j ) = (w n,j ) does not depend on n, or possibly variable to emphasize the general case. If w 1,1 = 1 and (w n,j ) does not increase in j for each n, then it is a tapering scheme. Suppose now that (w j ) = (w n,j ) is a fixed tapering scheme:
is said to be a weak tapering scheme.
Otherwise, (w j ) is said to be a strong tapering scheme.
(ii) The tapering scheme (w j ) is said to be regular if it can be written w 2 j = j −r1 d(j) for some constant r 1 ≥ 0 and sequence d(j) = (log j) r2(j) for which r 2 (1) = 0, r 2 (j) ≤ 0 when r 1 = 0, r 2 (j) = o(log j/ log log j), both r 2 (j) and {r 2 (j) − r 2 (j − 1)} are eventually monotone, and if r 2 (j) does not decrease then for sufficiently large j, k j > j, and for each
The exponent r 1 and sequence r 2 (j) are called the the degree and logarithmic degree sequence of (w j ), respectively.
Our first detailed performance description compares rates of testing across the various categories of weighting schemes. Before stating the result, however, let us first clarify a notation convention that should be assumed throughout the remainder of discussion. Observe that the objects S n , W n , and U n defined in Theorem 1 summarize key properties of a given weight sequence (w n,j ). Notation will reference these objects as indicated for a weighting scheme denoted (w n,j ), which will be obvious in context. Consistency in distinguishing marks should also be assumed. For instance, if the weighting scheme is denoted (w j ), the corresponding summaries are denotedS n ,W n , andŨ n . Similarly, for fixed weighting schemes (w j ) = (w n,j ) the subscript n is dropped so that S = S n , W = W n , and U = U n .
The result is now stated as a corollary to Theorem 1.
Corollary 1.1. Fix s > 1/2, M > 0, and suppose (w n,j ) is a weighting scheme, (p n ) is a refinement scheme, and (δ n ) is a separating sequence.
(i) Suppose (w n,j ) is the variable tapering scheme defined byw n,j = min{w n,k /w n,1 : k ≤ j}
(ii) If (δ n ) is allowed by (w n,j ) then there is a separating sequence (δ n ) such thatδ n ≤ δ n for each n and a fixed tapering scheme (w j ) by which (δ n ) is allowed.
(iii) Suppose (δ n ) is a separating sequence and (n k ) is an index subsequence for which
there exists a separating sequence (δ n ) that is (p n )-allowed and an index sequence (n k ) for which δ n k ≤δ n k ≤ δ n k −1 and n u kδ n k → ∞ for every u > 0.
(iv) If (w j ) is a weak tapering scheme and (δ n ) is (p n )-allowed by (w j ), then there is a regular tapering scheme (w j ), a separating sequence (δ n ) that is (p n )-allowed by (w j ), and an index sequence (n k ) such that δ n k ≤δ n k ≤ δ n k −1 . The sequence (w j ) may be taken as any regular tapering scheme for which w j ≥w j for every j and w j k =w j k along some index
This corollary is an important technical result which is especially useful for establishing general performance bounds on the tapering approach. As describe above, it begins by bounding the performance of general weighing schemes by that of tapering schemes, then bounds that performance by the performance of fixed tapering schemes, etc., until it becomes clear that the performance of any weighting scheme is bounded by that of the regular tapering schemes (which will be described later in Section 2.2). Some specific nuances in the interpretation of Corollary 1.1 are as follows. Statement (i) establishes there is no benefit in terms of performance to weighting schemes that do not taper, and it is always possible to modify a scheme so that it does, without incurring a loss in performance. Statement (ii) suggests that the fixed tapering schemes bound the performance of all tapering schemes, but does not identify specific substitutes that are independent of the particular separating sequence under evaluation. Among fixed tapering schemes, statement (iii) shows that strong tapering schemes yield very poor performance, while statement (iv) identifies for any weak tapering scheme a regular tapering scheme that bounds its performance. Note also, by comparison with (10), that the last assertion of statement (iv) establishes that the rates of testing of regular tapering schemes are true "rates" in that they do not depend on leading constants.
The next part of the discussion seeks to involve the role of the refinement scheme in determining rates of testing. The following definition provides a relevant terminology and the subsequent corollary establishes basic ideas.
Definition 3. Fix s > 1/2, M > 0 and suppose (w j ) is a weighting scheme. A refinement scheme (p n ) is said to be allowed by (w j ) at (s, M ) if there exists a separating sequence (δ n )
In that case, the rate at which p n → ∞ defines the minimal rate of refinement for (w j ) at (s, M ). Reference to specific (w j ), s, or M may be omitted when obvious in context.
Basic properties of allowed refinement schemes are connected to other relevant parameters as follows.
Corollary 1.2. Fix s > 1/2, M > 0 and suppose (w n,j ) is a weighting scheme.
(ii) Suppose (w n,j ) is a tapering scheme. A separating sequence (δ n ) is minimally allowed if it is minimally (p n )-allowed for some refinement scheme (p n ) that is minimally allowed.
The first statement of this corollary is important for establishing both upper and lower bounds on the rate at which dimensionality may increase to preserve good performance. Most interesting is the first relationship p −1 n = O(n −2/s ), which identifies a minimum rate at which dimensionality is to increase. This lower bound is universal in the sense that it depends neither on the weight sequence nor the separating sequence, and moreover since s > 1/2 it implies
identifies an upper bound, and will be important later in Section 3.1, for investigating the sensitivity of test performance on the rate of p n . The second statement lays out a strategy for deducing unconditional rates of testing: a minimally allowed separating sequence may be found as the minimally (p n )-allowed separating sequence of a minimally allowed refinement scheme (p n ). This too will be demonstrated in 
Rate characterizations and performance bounds
Enough ideas are now in place to deduce precise rate characterizations, and to establish performance bounds.
The following result builds on the implications of Corollary 1.2.ii, by establishing general criteria for minimally allowed refinement schemes and minimally (p n )-allowed separating sequences.
Theorem 2. Fix s > 1/2 and M > 0, and suppose (w n,j ) is a weighting scheme.
At least one such refinement scheme exists.
(ii) For a given allowed refinement scheme (p n ), the separating sequence (δ n ) is minimally
At least one such separating sequence exists.
Theorem 2 provides a means to carry out the strategy for deducing rates of testing that is implied by Corollary 1.2.ii. It is seen that if (w n,j ) is a tapering scheme and (p n ) is as in statement (i), above, then statement (ii) implies that the setting δ n = M p −s n defines a separating sequence (δ n ) that is minimally allowed. Thus, to find a rate of testing, all that is needed is to find a minimally allowed refinements scheme. To aid in this process, the following corollary gives explicit formulas for minimal rates of refinement across a large class of regular tapering schemes. The second statement provides a formula for conditional rates of testing of testing as well, which admits broader evaluation under arbitrary refinement schemes.
Corollary 2.1. Fix s > 1/2 and M > 0. Suppose (w j ) is a regular tapering scheme with degree r 1 and logarithmic degree sequence r 2 (j) = O( √ log j/ log log j); write d(j) = (log j) r2(j) and set c = 1/(s + r 1 − 1).
(i) A refinement scheme that is minimally allowed may be specified according top n = n 2/s if
bounded or r 3 (j) = log S(j)/ log log j is such that r 3 (j) − r 3 (j − 1) is eventually monotone.
(ii) For a given allowed refinement scheme (p n ), a separating sequence that is minimally (p n )-
The next theorem is concerned with performance bounds rather than rate characterizations.
It may be seen as a continuation of Corollary 1.1, supplementing those performance bounds with bounds for regular tapering schemes. The results are stated using the transformation a n = {n 2 δs /s n } −1 , which describes the relative rate at which a given separating sequence slows down from Ingster's minimax rate. In this notation, Ingster's minimax rate is a n ≍ 1 and if a n → 0 then a slower rate of convergence indicates better performance. (See Section 3.1 for further discussion.) The object a n is the reciprocal of Spokoiny's "adaptive factor," but is preferred here since the associated performance bounds are easy to state using standard order notation.
Theorem 3. Fix s > 1/2 and M > 0. Suppose (w j ) is a regular tapering scheme of degree r 1 and logarithmic degree sequence r 2 (j), (p n ) is a refinement scheme, (δ n ) is a separating sequence that is (p n )-allowed by (w j ), and set a n = {n 2 δs /s n } −1 .
Part A. Suppose 0 ≤ r 1 < 1. If lim inf n log p n / log n ≥ B for some lower bound B > 2/s, then a n = o (n −t ) for every 0 < t < γ, where γ = (Bs − 2)(1 − r 1 )/{s − (1 − r 1 )} > 0.
Part B. Suppose r 1 = 1 and r 2 (j) → ∞.
(i) If both r 2 (p n k )/ log log p n k → ∞ and lim inf k log p n k / log n k > 2/s for some index sequence
(ii) If r 2 (p n ) = O(log log p n ) and lim inf n log p n / log n > 2/s then a n = o((log n) −1 ).
Part C. Suppose r 1 = 1 and r 2 = lim j r 2 (j) < ∞.
(ii) If r 2 (j) → −1, then a n = o((log n) −1 ).
(iii) If S(p n ) converges, then r 2 = lim j r 2 (j) ≤ −1 and, for any t > 0, a n = o((log n) −t ) if lim j r 2 (j) = −∞ and a n = o((log n) r2+t ) otherwise.
Theorem 3 covers all subclasses of the regular tapering schemes, and establishes the bound a n = O((log n) −1 ) for the adaptive context. To see this latter assertion, consider the role played by refinement schemes. Suppose 1/2 < s * < s * , (δ n (s)) are separating sequences indexed by s, (w j ) is a fixed tapering scheme, and (p n ) is a refinement scheme. Observe the relationship p −1 n = O(n −2/s ) of Corollary 1.2.i implies that if (p n ) is allowed at every s * < s < s * it must satisfy lim inf n log p n / log n > 2/(4s * + 1). Yet, this means lim inf n log p n / log n > 2/s for every s * < s < s * . Now if each separating sequence (δ n (s)) is (p n )-allowed at s, one may check each part of Theorem 3 to verify that lim inf n log p n / log n > 2/s implies at each s there is an index
then extends this bound to the tapering mechanism in general. Moreover, Example 3 of Section 3.1, below, will demonstrate a (w j ) for which a n (s) ≍ (log n) −1 is possible for such (δ n (s)).
It is therefore appropriate to call {n 2 (log n) −1 } −s/s an optimal adaptive rate of testing for the tapering mechanism.
Interpretation and implications for FDA
In this section, the technical results of Section 2 are interpreted and translated into recommendations for how to configure tapering mechanisms in FDA applications. The discussion will
present several examples to demonstrate the use of Theorem 2 and Corollary 2.1, and to study the behavior of rates of testing in several important cases. A key result is the identification of a class of tests that are adaptively optimal for the tapering mechanism. As indicated in Section 1.2, an important concern in FDA is a test's sensitivity to the rate at which dimensionality increases, hence this property will be given special attention.
Rates of testing for example tapering schemes
On the whole, the presentation of this section is at a lower technical level than that of Section 2. However, the terminology of Definitions 1-3 shall be used, and the notation of Theorem 2
and Corollary 2.1 should be assumed as well. It will also help to recall the notation S n (p) =
Evaluation of the examples below shall focus on the transformation a n = {n 2 δs /s n } −1 , where (δ n ) is taken to be an allowed separating sequence. This was introduced in Section 2.2, immediately prior to the statement of Theorem 3. Recall this transformation describes the slowdown from Ingster's minimax rate, and is convenient for expressing performance bounds using order notation. For instance, Ingster's bound is a n = O(1) and Spokoiny's bound on adaptive rates is a n = O((log n log n) −1 ). Recall further that Theorem 3 establishes the bound a n = O((log n) −1 ) on adaptive rates for tests based on quadratic forms, although a n ≍ 1 is possible nonadaptively.
Sequences (δ n ) for which a n = O(n −t ) for some t > 0 will be considered to reflect poor performance.
The first example reconsiders the optimal tests described in Ingster (1993) , and generalizes them to a broader class of optimal class based on quadratic forms. However, it is also shown the performance of this class suffers severely when the rate at which dimensionality increases is misspecified.
Example 1. Suppose the weight sequence is defined according to w n,j = j −r1/2 for some fixed constant 0 ≤ r 1 < 1. In this case S(p) ≍ p 1−r1 , and so, by Corollary 2.1.ii, a conditional rate
, where c = 1/(s + r 1 − 1). If one writes p n ≍ n 2/γ for some γ, the expression simplifies toδ n ≍ n −2sc{1−(1−r1)/γ} , for which a n ≍ n −2[1+sc{1−(1−r1)/γ}] . By Corollary 2.1.i, the setting γ =s makes p n =p n ≍ n 2/s minimally allowed, in which case the corresponding rate of testing, now unconditional, isδ n ≍ n −2s/s .
It has therefore been shown that tests defined from this class of weight sequences can achieve
Ingster's minimax rate of testing. However, suppose instead thatp n ≍ n 2/s is incorrectly specified as p n ≍ n 2/γ for γ =s. Then eitherδ n is not (p n )-allowed, if γ >s, which follows from Corollary 1.2.i, or a n = o(n −2t ) for 0 < t < 1 +sc{1 − (1 − r 1 )/γ}, if γ <s. Either case leads to a drastic degradation of performance.
The next example reconsiders the optimal tests deduced in Fan, Zhang, and Zhang (2001) , and generalizes them also to a broader class of optimal tests. Then, distinguishing its properties from the tests of Example 1, it is shown this class is robust with respect to the rate at which dimensionality increases, and is therefore more suited to FDA applications.
Example 2. Suppose w n,j = 1 − {j r ξ n /(1 + j r ξ n )} m for some r ≥ 0, m = 1, 2, . . ., and (ξ n ) a positive sequence with ξ n → 0. Observe that if (w n,j ) is specified in such a way that ξ n ≤ Bp −r n for some constant B > 0, it follows that w n,j ≥ C = 1 − {B/(1 + B)} m for j = 1, . . . , p n , hence
Thus, by Theorem 2,p n = n 2/s gives a minimal rate of refinement and δ n = n −2s/s a rate of testing, matching Ingster's minimax performance bound.
Interestingly, when r > 1 and ξ n ≍ n −2r/s this (δ n ) is also minimally (p n )-allowed for any refinement scheme (p n ) for whichp n = O(p n ), suggesting the parameter ξ n can lend protection against misspecification of the refinement scheme. To see this, consider Lemma 5 of Section 5, which establishes thatp n = o(p n ) implies S n (p n ) ≍ n 2/s under these settings. Thus W n (q n ) → 1, whereq n = {δ n /M } −1/s , U n (p n ,q n ) ≍q n n −2/s ≍ 1, and Theorem 2.ii gives the result.
These settings are consistent with those selected by Fan, Zhang, and Zhang (2001) for the infinite quadratic form Q ∞ n , discussed in Section 1.3, which are m = 2, r = 2s, and ξ n = n −4s/s .
As noted, that test also achieves minimax performance, and does so with what might be viewed as a refinement scheme that diverges at an arbitrarily fast rate.
Let us now turn our attention to the adaptive context. Theorem 3 establishes that no test based on a quadratic form can achieve Spokoiny's adaptive-minimax rate, but the next example identifies a class of such tests that are adaptively optimal for the tapering mechanism.
Example 3. Suppose w n,j = {j −1 (log j) −(1−λ2) } −1/2 for some λ 2 ≥ 0. Here S(p) ≍ (log p) λ2 so that r 2 (j) = λ 2 − 1 and c = 1/s in Corollary 2.1.ii, which identifies a conditional rate of testinĝ
The minimal rate of refinement given by Corollary 2.1.i isp n = {n 2 d(n 2c ) / S(n 2c )} c ≍ {n 2 (log n) −1 )} 1/s , which yields the unconditional rate of testingδ n ≍ {n 2 (log n) −1 } −s/s . Thus a n ≍ (log n) −1 and the adaptive bound on the tapering mechanism has been achieved.
Note here that if (p n ) is incorrectly specified, but still logp n ≍ log n (and 10.i holds), the relationship a n ≍ (log n) −1 does not change. This means that suitable refinement schemes can be specified independently of s. One choice sets p n = n 2/3 , which satisfies (10.i) for any s > 1/2. Though logp n ≍ log n does not allow arbitrarily fast rates of dimensionality increase, it nevertheless gives fairly wide leeway for possible misspecification of the refinement scheme.
The last example analyzes a class of tests that generalize the Cramér-von Mises goodness-offit test, described in Section 1.1. It illustrates how heavy tapering can lead to poor performance.
Example 4. Suppose w n,j = j −r1/2 for some r 1 > 1. For instance, the setting r 1 = 2 admits an examination of the Cramér-von Mises goodness-of-fit test, through a subsequence described in Corollary 1.1.iv. This weight specification leads S(p) to converge, thus Corollary 2.1.ii identifies a conditional rate of testing given byδ n = {b n d(b c n )} −sc ≍ n −2sc , where c = 1/(s + r 1 − 1). This rate is independent of p n , and so gives an unconditional rate of testing as well, provided (p n ) satisfies (10.i). For instance, a minimal rate of refinement isp n = {n
as deduced from Corollary 2.1.i. The poor performance of this class of tests may be observed in noting a n ≍ n −2(1−sc) = o(n −2t ) for 0 < t < 1 −sc, one of which always exists sincẽ sc =s/(s + r 1 − 1) < 1 under these settings.
Implications for FDA
Having now demonstrated the use of Theorem 2 and Corollary 2.1 and investigated the performance of the tapering mechanism, the issue of making practical recommendations for the use of quadratic forms in FDA is now addressed. Recall from Section 1.2 that the rate at which p n → ∞ cannot be controlled in FDA, and so care is needed in interpreting results that depend on a specific refinement scheme. One caution and two recommendations shall be made.
The caution is that the global perspective of the functional linear hypothesis, discussed in Section 1.2, makes it hard to justify any artificial control over p n by setting it to a desired function of n. For instance, one might think to set p n = n 2/s to optimize performance of the weighting schemes in Example 1. Such an approach would however conflict with the global perspective of the functional linear hypothesis, and is unsatisfactory, since by ignoring the Y n,j associated with j = p n + 1, . . . , p, it conveys an unappealing sense that the test "throws out" data.
The first recommendation is to abandon attempts to achieve Ingster's minimax rate using a fixed tapering scheme, for they are doomed when (p n ) cannot be controlled. The basis of this recommendation is the remarks following Theorem 3, which shed light on a link between the notions of adaptivity with respect to s and misspecification of the refinement scheme. Specifically, it is deduced that among fixed tapering schemes minimax optimality is destroyed by misspecification of (p n ), as is demonstrated in the tests of Example 1. The two concepts should not be confused, however, for Example 2 demonstrates a variable tapering scheme that achieves minimax optimality under any allowed refinement scheme. Following on this last point, let us furthermore append our recommendation with encouragement to apply the weighting schemes of Example 2 in cases where s is specified exactly.
The second recommendation is to apply in situations where s is left unspecified a weighting scheme of the class w n,j = {j −1 (log j) −(1−λ2) } −1/2 for λ 2 ≥ 0, as in Example 3. This class is broadly suitable since it is forgiving to misspecified (p n ), while at the same time produces an adaptively optimal rate of testing. A good general recommendation is to set w j = j −1/2 , for simplicity. While the requirement log p n ≍ log n for adaptive optimality does limit the faster rates of (p n ), the range of suitable (p n ) is so very wide that this limit would be of little concern except in very specialized problems. A potential future improvement would be to find a variable tapering scheme that is adaptively optimal for any setting of (p n ) that diverges at a sufficiently fast rate,à la the minimax tests of Example 2. This possibility has neither been identified nor ruled out
Concluding discussion
Criteria determining rates of testing for tests based on tapering have been deduced, and have led to general performance bounds, and performance characterizations for individual tests. The rate δ n = {n 2 (log n) −1 } −s/s has been identified as adaptively optimal for the tapering mechanism.
The tapering scheme (w j ) defined by w j = j 1/2 has been shown to achieve this optimal-adaptive rate, and also to protect against misspecification of (p n ), which is an important concern in FDA.
That setting is recommended for generic use in FDA in situations where one is compelled to apply the tapering mechanism. Extensions of Fan, Zhang, and Zhang's (2001) optimal tests have been made and shown to be robust against misspecification of p n . This class is recommended for situations where s is known exactly.
It is worthwhile to comment further on the relevance of results to modified versions of the testing problem, and on other scenarios that involve functional models. A common modification of (3) replaces the null hypothesis with H 0 : θ j = θ 0,j for j = 1, . . . , p n and (θ 0,1 , θ 0,2 , . . .) ∈ B s,M , which may be tested by similarly replacing (4) with Q n = n pn j=1 w j Y n,j − θ 0,j 2 , provided (6) is also modified by increasing M to √ 2M .
The recent work of Gayraud and Pouet (2005) consider rates-of-testing theory for general composite null hypotheses. The tapering approach is generally limited by the compatibility of quadratic forms primarily to regions with ellipsoidal contours. (These shapes are covered by the functional linear hypothesis of Section 1.) Nevertheless, a careful examination of the proof of Theorem 1 will indicate that consideration of oddly-shaped composite null hypotheses would lead to criteria similar to (10), but with the function W n redefined.
Other relevant composite hypotheses would reflect an interest in testing H 0 across a subset of dimensions j ∈ J n ⊂ {1, . . . , p n } such that J n ⊂ J n+1 and max J n → ∞. A corresponding modification of the testing setup would revise the indices in (4) to j ∈ J n , and those of (6) and (8) to j ∈ ∪ n J n . For some specifications of the J n , the revised geometry would be equivalent to (6), in which case present results would be directly relevant for evaluating weighting schemes (w n,j k ) along j k ∈ ∪ n J n . For instance, a relevant FDA scenario would consider just the even indices of a Fourier decomposition (i.e., the cosine-terms), which translates to an interest in just the symmetric attributes of the data. Here, J n = {2j ≤ p n }, for which the revised sum in (6) is j∈∪nJn j 2s θ j 2 = 2 2s ∞ j=1 j 2s θ 2j 2 , which is equivalent to (6) on its associated space.
The choice of using the Fourier basis in Section 1.2 reflects a modeling assumption of stationary curves, but other situations might call for an alternate choice of basis, provided it decorrelates the model. (For model 1, an appropriate basis would be defined of the space of functions square-integrable on (0, 1] with respect to the standard inner product < f, g >= f gdλ, where λ is Lebesgue measure). Wavelet basis functions are often an attractive alternative in situations where it is necessary to consider a geometric framework more general than (6), such as Besov balls. For instance, they are the method of choice in Abramovich et al. (2004) .
Existing theory also implies that Fourier decomposition of individual stationary processes leads to (2), asymptotically, with each Y n,j following an exponential distribution. This suggests a potential usefulness of adapting the present results to exponential models, or more broadly to exponential-family distributions.
Another well-known route to (2) originates in goodness-of-fit testing, which inspires many of the testing procedures used in FDA. (Refer to the references cited in Section 1.1 for further discussion.) In goodness-of-fit testing, p n is usually much smaller than in FDA, and can typically be controlled, unlike in FDA. (E.g., it is often set to a default rate of p n = n.) Nevertheless, it is expected that some aspects of Section 2 would have considerable relevance to the goodness-of-fit testing problem as well as FDA.
Proofs
Proof.
The stated moment conditions and (9) imply
for which A n ≍ 1 and B n (θ) is uniformly bounded. By Chebyshev's inequality, the critical value for a size α test that rejects for large Q n is νR n (p n ) + C n A n S n (p n ) for C n ≍ 1. The Cauchy-Schwartz inequality provides |T n (p, θ)| ≤ νS n (p) θ 2 2,n (p), so that the power of the test may be written
. Since E θ [Q n ] = 0 and V θ [Q n ] = 1, the probability above converges to one if the right term inside diverges to −∞. The property P [e jk ≤ −t] > 0 for each t > 0 implies P θ [Q n ≤ −t] > 0 for each t > 0, hence such divergence is also a necessary condition. Criterion (7) is therefore equivalent to
for every δ n → 0. However, since w n,j ≤ 1 one has θ
Therefore (11) implies n θ 2 1,n (p n ) → ∞, and so also (12).
To derive equivalent conditions for (11), consider the following. For θ ∈ B s , one has
wherep n is the index j ≤ p n that minimizes w n,j . Therefore, θ at anyθ = (θ 1 ,θ 2 , . . .) for which θ j = δ n /δ * n if j =ĵ n and θ j = 0 otherwise, whereĵ n is the index j ≤ {δ n /(M δ * n )} −1/s that minimizes w n,j . Then
It follows that for (11) to hold for every δ * n → 0, the following criteria must be satisfied lim sup n→∞ nw n,pn p
−2s
n / S n (p n ) < ∞, and
(An finite limit superior is required in (13), since the sequence in (14) can be slowed down arbitrarily by a suitable choice of δ * n .) Squaring the sequence in (13) leads to the equivalent criterion (10.i).
To derive (10.ii), take the square of the sequence in (14) and rewrite to form the equivalent
Noting that the term in braces may tend to infinity at an arbitrarily slow rate (since {δ n /δ * n } −1/s ≤ δ −1/s n and W n (p) does not increase in p), it is seen that the criterion (10.ii) is also equivalent.
, which implies that (10) holds for (w n,j ), (p n ), and (δ n ).
To prove statement (ii), denote by (p n ) a refinement scheme for which (δ n ) is (p n )-allowed by (w n,j ); also write q n = ⌊{δ n /M } −1/s ⌋, where ⌊j⌋ for the largest integer not to exceed j. Ingster's performance bound δ n = O(n 2s/s ) translates here to lim inf n n 2 q −s
exists since k −2 qs k → 0) so thatq n ≥ q n always and neither (q n ) nor (n 2q−s n ) ever decreases. Fix n 0 = min{q n ≥ 1} and define the nonincreasing sequence (c j ) according to c 1 = 1, cq n = n −2qs n for n ≥ n 0 , and c j = min{c k : k ≤ j}. Then use Lemma 2.iii to construct (w j ) so thatŨ(p) = c p for each p. It follows that n 2Ũ (q n )q
To prove statement (iii), fix u > 0, set t > 2s/u −s + 1, and observe
, where v = u{s + t − 1}/(2s) > 1. Thus if (10.ii) holds, it must be that n u kδ n k → ∞. The second assertion is proven as follows. Denote by (j k ) a subsequence for which j t k w j k → 0 for every t > 0.
Define the separating sequence (δ n ) by first compiling an index sequence (n k ) such that each k
since δ n k ≤δ n k and W (p) does not increase. It is then easily checked that if (10.ii) holds for (δ n ), it must also hold for (δ n ).
To prove statement (iv), first set r 1 = inf{t : j t w j → ∞}, which must exist since (w j )
is weakly tapering, and r 2 (j) = log{j r1 w 2 j }/ log log j. If r 2 (j) > lim inf j r 2 (j) for sufficiently large j, letr 2 (j) be the convex function formed by the taught string under the graph of r 2 (j).
If r 2 (j) ≤ lim inf j r 2 (j) infinitely often, letr 2 (j) be any concave function formed by a taught string under the graph of r 2 (j), but with j on a logarithmic scale. (Suchr 2 (j) exist since r 2 (j) = o(log j/ log log j).) A regular tapering scheme (w j ) is then given byw j = j −r1 (log j)r 2 (j) .
The sequence (δ n ) may be constructed in a parallel manner as the (δ n ) of statement (iv), but here taking as its starting point the subsequence (j k ) for which w j k =w j k (which leads toδ
Proof. (Corollary 1.2) Statement (i) is proven as follows. The property p
is established by noting Lemma 2.ii and that (10.i) may be read p
The property p
n ) is established by applying Ingster's performance bound
The property S n (p n ) = o(n 2 ) must hold since otherwise (10.ii) cannot hold for any δ n → 0. To prove the final assertion of the statement, define the refinement scheme (p * n ) according to p * n = max{⌊p⌋ :
, and note that n 2 U n (p * n )p * −s n → 1. Writing γ * n = log p * n / log n, this means {1 − (s/2)γ * n } log n + log U n (p * n ) → 0, and since log U n (p * n ) ≤ 0, by Lemma 2.ii, it must be that lim inf n γ * n ≤ 2/s. By (10), this also means the separating sequence (δ * n ) given by δ *
Hence if (p n ) is minimally allowed it must be that p n = O(p * n ), which, writing γ n = log p n / log n, implies lim sup n (γ n − γ * n ) ≤ 0, as required.
To prove statement (ii), suppose (p n ) is minimally allowed, (δ n ) is minimally (p n )-allowed, (p * n ) is a refinement scheme, and (δ * n ) is a separating sequence for which δ * n k = o(δ n k ) for some index subsequence (n k ). Since (δ n ) is minimally (p n )-allowed it cannot be that (δ this would imply S n k (p −s n ≍ 1 that (p n ) is allowed since then the separating sequence (δ n ) given by
If another refinement scheme (p * n ) is such that p *
is not allowed and so (p n ) is minimally allowed. Note that p n = max{⌊p⌋ :
proven similarly, using the property that W n (p) does not increase in p. Note that δ n = M q −s n with q n = max{q :
Proof. (Corollary 2.1) To prove statement (i), first observe that in the case 0 ≤ r 1 < 1,
, noting Lemma 6.v and its implication c n = c + o(1/ √ log n), as well as the stated assumptions on r 2 (j) and r 3 (j). To prove statement (ii), first observe that
One has b n → ∞, by Corollary 1.2.i, and c n = c + o(1/ √ log b n ), so that Lemma 4.i provides
To prove Part A, note Lemma 3.iii provides that U (p n ) ≍ 1 in this case, and so by (15), the rate of a n is completely determined by that of R(p n , q n ). For any 0 < u, v < 1 − r 1 , one
Thus if lim inf n log p n / log n ≥ B for some B > 2/s,
and so, lim sup n log(n t a n )
which is negative for 0 < t < γ and sufficiently small u, v > 0. It follows that log(n t a n ) → −∞, as required.
To prove Part B, first set b n = log q n / log p n and observe that lim inf k log p n k / log n k ≥ B > 2/s for some (n k ) implies lim sup k b n k < 2/(Bs) < 1. To see this, consider that, by Corollary 1.2.i, any minimally allowed refinement scheme (p n ) has lim sup k logp n k / log p n k ≤ 2/(Bs). By Corollary 2.i, at least one such (p n ) exists. Thus if lim sup k b n k < 2/(Bs) < 1 did not hold then lim inf k log q n k / logp n k > 1, which contradicts the propertyp
Note in this case that lim sup k b n k < 1 also implies r 2 (q n k ) ≤ r 2 (p n k ) eventually, which means
To prove Part B.i, set c n = r 2 (p n )/ log log p n , and observe that
for any t > 0, where h(p) = log log p. Since log n = O(log p n ), by Corollary 1.2.i, and U (p n ) ≤ 1, by Lemma 3.iii, (15) then provides the result. To prove Part B.ii, redefine c n = r 2 (p n )/ log log log p n , and separately consider the cases c n k → ∞ for some (n k ) and c n = O(1). In the former case, observe that U (p n ) = O(log log n/ log n), by Lemma 6.iii, and so (15) provides
where h(p) = log log log p. If instead c n = O(1), fix c such that lim sup n b n < c < 1, observe that U (p n ) = O(c −r2pn / log p n ), by Lemma 6.iv, and so (15) provides
The property log n = O(log p n ), from Corollary 1.2.i, then gives the result.
To prove Part C, observe that by Theorem 2 and Corollary 1.2.ii, it is enough to check the case where n 2 U (p n )p −s ≍ 1, so that (p n ) is minimally allowed, and q n = p n . Thus, in proving part Part C, lim n log p n / log n = 2/s, as in Corollary 1.2.i, should be assumed. Furthermore, observe that, through (15), the rate of the adaptive factor is completely determined by that of U (p n ). With this in mind, statement C.ii is established immediately by Lemma 6.vi, which gives r 2 (j) → −1 implies U (p n ) = o((log n) −1 ). Statement C.i is established by first noting that if r 2 (j) = r 2 then Lemma 1 along with the relationship j −1 (log j)
ii extends this to the case r 2 (j) → r 2 through comparison with cases where r 2 (j) =r 2 for −ǫ <r 2 − r 2 < ǫ. Statement C.iii is proven as follows. When S(p) converges, the upper bound r 2 = lim j r 2 (j) ≤ −1 is clear since p j=1 {j log j} −1 ≍ log log p diverges. In this case,
The case of Part D is such that S(p) converges. Fix 0 < t < 2{1 −s/(s + r 1 − 1)} and set u =st/(2 − t). Observe these setting specify t < 2, 0 < u < −(1 − r 1 ), and 2 − (2 − t)(s+ u)/s = 0. The criterion (10.ii) is equivalent to lim inf n→∞ n 2 q −s−u n q 1−r1+u n (log q n ) r2(qn) > 0, which requires n −2 qs +u n → 0 since j 1−r1+u (log j) r2(j) → 0. One therefore has n t a n = n t−2 qs n = n 2−(2−t)(s+u)/s n −2 qs +u n s/(s+u)
Proof. This is a discrete version of L'Hospital's rule, and can be proven similarly (see, e.g., Rudin, 1976) . Proof. To prove statement (i), first note that
does not decrease in p. If p n > p * n , then since w 2 n,j ≤ 1 does not increase in j it must be that
which proves the statement. To prove statement (ii) observe if p ≤ q one has {U n (p, q)}
U (p) ≍ 1 whenever there is a t > 0 for which j 1−t w 2 j → ∞.
Proof. To prove statement (i), write ii. An associated lower bound is deduced by fixing some t > 0 for which j 1−t w some r > 1, m = 1, 2, . . ., and (ξ n ) a positive sequence with ξ n → 0. Let (p n ) be a refinement scheme for which p r n ξ n → ∞, and define H(x; r) = r statement (v), write T 3 (p n , ξ n , r) = aT 1 (p n , ξ n , r) + T 2 (p n , ξ n , r), where a, T 1 , and T 2 are as in
(ii) and (iv). It follows that T 3 (p n , ξ n , r)−T 3 (p n −1, ξ n , r) ≍ w 2 n,pn , hence S n (p n ) ≍ T 3 (p n , ξ n , r).
Moreover, T 2 (p n , ξ n , r) ≍ p n (p r n ξ n ) −1 and (i) provides aT 1 (p n , ξ n , r) ≍ p n (p r n ξ n ) −1/r = ξ −1/r n , the latter term leading in T 3 (p n , ξ n , r). follows from (ii) with b(j) = log j/ log log j andh(x) = log x. Statement (iv) follows from (ii) with b(j) = c r2(j) log j andh defined ash(log j) = r 2 (j) for integer-valued j, interpolated otherwise (for which logarithmic concavity of Definition 2.ii is needed to apply statement ii).
Statement (v) is proven by first using (ii) with b(j) = √ log j andh(x) = √ x/ log x to establish U (p) = O(1/ √ log p). Lemmas 1, 3.i then give the result. To prove statement (vi), first observe that r 2 (j) → −1 implies w 2 j = o(j −1 (log j) t−1 ) for every t > 0. As j −1 (log j) t−1 ≍ {log j} t − {log(j − 1)} t , Lemma 1 implies S(p) = o({log p} t ) for every t > 0, which means log S(p) = o(log log p). Using log log j−log log(j−1) ≍ (j log j) −1 , Lemmas 1, 3.i then provide (log p)U (p) ≍ p(log p){log S(p) − log S(p − 1)} → 0.
